Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbp
|
ENSMUSG00000014767.10 | TATA box binding protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_15499739_15500366 | Tbp | 92 | 0.752664 | -0.24 | 7.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_124035672_124036030 | 16.81 |
Gm12902 |
predicted gene 12902 |
109617 |
0.05 |
chr2_65995126_65995501 | 12.66 |
Gm13617 |
predicted gene 13617 |
41243 |
0.15 |
chrX_42361483_42361664 | 11.78 |
Gm14619 |
predicted gene 14619 |
14061 |
0.27 |
chr6_94773287_94774569 | 11.02 |
Gm43997 |
predicted gene, 43997 |
25504 |
0.15 |
chr3_34411859_34412208 | 10.23 |
Gm34599 |
predicted gene, 34599 |
4462 |
0.22 |
chr18_23037418_23037876 | 9.93 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr2_145859511_145860521 | 9.87 |
Rin2 |
Ras and Rab interactor 2 |
2628 |
0.24 |
chr16_16485604_16485955 | 9.84 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
18443 |
0.18 |
chr7_129937635_129938453 | 9.82 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr10_13883385_13883581 | 9.62 |
Gm32105 |
predicted gene, 32105 |
190 |
0.91 |
chr17_13654565_13655321 | 9.35 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr9_10269473_10269801 | 9.28 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr9_39558349_39558520 | 9.24 |
Olfr958 |
olfactory receptor 958 |
4380 |
0.11 |
chr2_10737503_10737690 | 9.01 |
Gm18547 |
predicted gene, 18547 |
156113 |
0.01 |
chr17_84366034_84366339 | 8.98 |
Thada |
thyroid adenoma associated |
2594 |
0.3 |
chr12_27335450_27335676 | 8.63 |
Sox11 |
SRY (sex determining region Y)-box 11 |
7011 |
0.3 |
chr1_84890058_84890401 | 8.58 |
Fbxo36 |
F-box protein 36 |
21078 |
0.13 |
chr6_14755283_14755434 | 8.43 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
84 |
0.99 |
chr2_131845810_131845961 | 8.35 |
Gm14282 |
predicted gene 14282 |
290 |
0.64 |
chr16_94721521_94722246 | 8.31 |
Gm41505 |
predicted gene, 41505 |
11 |
0.98 |
chr1_32463374_32463525 | 8.26 |
Gm37999 |
predicted gene, 37999 |
10308 |
0.17 |
chr1_94503928_94504626 | 8.25 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr9_13246797_13247848 | 8.00 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr1_33947103_33947453 | 7.85 |
Gm28631 |
predicted gene 28631 |
16407 |
0.12 |
chrX_58018757_58019114 | 7.84 |
Zic3 |
zinc finger protein of the cerebellum 3 |
3765 |
0.29 |
chr2_49618925_49619098 | 7.78 |
Kif5c |
kinesin family member 5C |
287 |
0.94 |
chr10_25023823_25024169 | 7.74 |
Gm47715 |
predicted gene, 47715 |
23976 |
0.15 |
chr5_107497460_107497812 | 7.74 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr18_13896425_13897019 | 7.72 |
Gm50094 |
predicted gene, 50094 |
6748 |
0.26 |
chr14_121494258_121494578 | 7.70 |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
1949 |
0.3 |
chr4_66025392_66025654 | 7.69 |
Gm11484 |
predicted gene 11484 |
328326 |
0.01 |
chr11_19773955_19774265 | 7.66 |
Gm12029 |
predicted gene 12029 |
9542 |
0.2 |
chr8_26626235_26626624 | 7.61 |
Gm32050 |
predicted gene, 32050 |
1051 |
0.49 |
chr10_73821665_73822034 | 7.56 |
Pcdh15 |
protocadherin 15 |
18 |
0.99 |
chr16_30055443_30055780 | 7.51 |
Hes1 |
hes family bHLH transcription factor 1 |
8773 |
0.15 |
chr4_148783736_148784166 | 7.48 |
Casz1 |
castor zinc finger 1 |
20478 |
0.19 |
chr18_60925459_60925693 | 7.47 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
42 |
0.97 |
chr14_24617341_24617911 | 7.46 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr17_9543267_9543689 | 7.40 |
Gm49807 |
predicted gene, 49807 |
6213 |
0.28 |
chrX_6046872_6047632 | 7.29 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
201 |
0.92 |
chr13_83727942_83728228 | 7.25 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr10_81176405_81177305 | 7.25 |
Eef2 |
eukaryotic translation elongation factor 2 |
224 |
0.79 |
chr3_48846282_48846527 | 7.20 |
Gm37190 |
predicted gene, 37190 |
85455 |
0.1 |
chr6_55484275_55484600 | 7.13 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
24201 |
0.19 |
chrX_6173594_6173780 | 7.13 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
672 |
0.73 |
chr14_62034808_62035017 | 7.04 |
Gm47953 |
predicted gene, 47953 |
22593 |
0.23 |
chr4_22997622_22997922 | 7.04 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
59337 |
0.16 |
chr2_61454109_61454765 | 7.04 |
Gm22338 |
predicted gene, 22338 |
38329 |
0.2 |
chr8_47284778_47285157 | 7.03 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr3_145964525_145964925 | 6.95 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
23145 |
0.14 |
chr10_34508631_34508935 | 6.92 |
Frk |
fyn-related kinase |
25251 |
0.21 |
chr11_42420173_42420489 | 6.92 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
567 |
0.86 |
chr1_12991017_12991358 | 6.87 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
10 |
0.98 |
chr1_90203794_90204127 | 6.87 |
Ackr3 |
atypical chemokine receptor 3 |
20 |
0.98 |
chr12_117344591_117345571 | 6.83 |
Gm5441 |
predicted gene 5441 |
8059 |
0.29 |
chr3_131566380_131566679 | 6.82 |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
1594 |
0.46 |
chr18_63513596_63513938 | 6.74 |
Gm22560 |
predicted gene, 22560 |
3872 |
0.18 |
chr12_27076467_27076625 | 6.73 |
Gm9866 |
predicted gene 9866 |
38449 |
0.22 |
chr13_49316889_49317079 | 6.70 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
3327 |
0.24 |
chr1_185482435_185482586 | 6.67 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
4784 |
0.17 |
chr4_6945076_6945264 | 6.67 |
Tox |
thymocyte selection-associated high mobility group box |
45313 |
0.19 |
chr5_38159819_38160081 | 6.67 |
Nsg1 |
neuron specific gene family member 1 |
43 |
0.97 |
chr13_27312356_27312697 | 6.64 |
Prl6a1 |
prolactin family 6, subfamily a, member 1 |
101 |
0.92 |
chr6_25686769_25687229 | 6.61 |
Gpr37 |
G protein-coupled receptor 37 |
2793 |
0.38 |
chr2_165043149_165043683 | 6.60 |
Ncoa5 |
nuclear receptor coactivator 5 |
8549 |
0.14 |
chr1_169747607_169747817 | 6.59 |
Rgs4 |
regulator of G-protein signaling 4 |
70 |
0.98 |
chr14_69028957_69029191 | 6.57 |
Stc1 |
stanniocalcin 1 |
164 |
0.85 |
chr19_41746384_41746957 | 6.55 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr3_83098548_83099077 | 6.53 |
Dchs2 |
dachsous cadherin related 2 |
29136 |
0.13 |
chr9_72692034_72692248 | 6.51 |
Gm7265 |
predicted gene 7265 |
592 |
0.52 |
chr18_43394483_43394818 | 6.50 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1273 |
0.52 |
chr8_46210360_46210863 | 6.49 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr14_19920192_19920714 | 6.49 |
Gm48283 |
predicted gene, 48283 |
53473 |
0.1 |
chr7_43634574_43634837 | 6.46 |
Ceacam18 |
carcinoembryonic antigen-related cell adhesion molecule 18 |
2 |
0.95 |
chr3_66102086_66102567 | 6.40 |
Gm36973 |
predicted gene, 36973 |
2521 |
0.19 |
chr10_86426115_86426266 | 6.39 |
Syn3 |
synapsin III |
65707 |
0.08 |
chr2_85198006_85198625 | 6.38 |
Lrrc55 |
leucine rich repeat containing 55 |
1118 |
0.31 |
chr12_26635257_26635560 | 6.38 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr17_25803191_25803511 | 6.38 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
5734 |
0.05 |
chr1_104049444_104049595 | 6.37 |
Gm18447 |
predicted gene, 18447 |
262202 |
0.02 |
chr2_134189819_134190016 | 6.34 |
Hao1 |
hydroxyacid oxidase 1, liver |
364390 |
0.01 |
chr14_3948585_3949537 | 6.34 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr9_20703833_20704274 | 6.33 |
Olfm2 |
olfactomedin 2 |
22884 |
0.12 |
chr1_114358299_114358478 | 6.30 |
9330185C12Rik |
RIKEN cDNA 9330185C12 gene |
394254 |
0.01 |
chr3_134303047_134303415 | 6.30 |
Gm43559 |
predicted gene 43559 |
30721 |
0.13 |
chr2_135404212_135404371 | 6.27 |
Plcb1 |
phospholipase C, beta 1 |
155118 |
0.04 |
chr15_95217343_95217494 | 6.24 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr15_18211118_18211421 | 6.22 |
Gm8318 |
predicted gene 8318 |
47388 |
0.15 |
chr2_40643754_40643928 | 6.20 |
Lrp1b |
low density lipoprotein-related protein 1B |
13547 |
0.29 |
chr7_89464437_89464588 | 6.17 |
AI314278 |
expressed sequence AI314278 |
38173 |
0.11 |
chr3_5329635_5329932 | 6.16 |
Zfhx4 |
zinc finger homeodomain 4 |
88111 |
0.09 |
chr6_47367638_47368002 | 6.15 |
Gm18584 |
predicted gene, 18584 |
65269 |
0.11 |
chr15_64831813_64831972 | 6.14 |
Gm21798 |
predicted gene, 21798 |
14198 |
0.27 |
chr11_8779438_8779589 | 6.14 |
Gm11990 |
predicted gene 11990 |
27335 |
0.22 |
chr4_15550428_15550614 | 6.13 |
Gm11859 |
predicted gene 11859 |
18410 |
0.22 |
chr1_10254179_10254614 | 6.10 |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
21726 |
0.2 |
chr2_129699849_129700017 | 6.10 |
Pdyn |
prodynorphin |
89 |
0.97 |
chr16_73482275_73482426 | 6.07 |
Gm49680 |
predicted gene, 49680 |
2507 |
0.32 |
chr10_125388906_125389759 | 6.06 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr9_41582201_41582428 | 6.06 |
Mir125b-1 |
microRNA 125b-1 |
388 |
0.42 |
chr10_17330771_17331243 | 6.05 |
Gm47760 |
predicted gene, 47760 |
1870 |
0.39 |
chr12_39956297_39956455 | 6.01 |
Gm18939 |
predicted gene, 18939 |
5744 |
0.21 |
chr16_91173819_91174057 | 6.01 |
Gm49613 |
predicted gene, 49613 |
1396 |
0.29 |
chr3_18054074_18054270 | 6.00 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
2 |
0.98 |
chr4_31727820_31728120 | 5.99 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
236127 |
0.02 |
chr16_77238960_77239248 | 5.98 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2785 |
0.32 |
chr13_41729696_41729998 | 5.98 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr6_39242951_39243777 | 5.98 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr10_80145825_80146996 | 5.97 |
Midn |
midnolin |
1862 |
0.15 |
chr3_107528740_107529014 | 5.97 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
10859 |
0.17 |
chr5_44473970_44474128 | 5.96 |
Gm42981 |
predicted gene 42981 |
21372 |
0.13 |
chr3_109782232_109782939 | 5.96 |
Ntng1 |
netrin G1 |
50674 |
0.16 |
chr4_110152119_110152431 | 5.94 |
Elavl4 |
ELAV like RNA binding protein 4 |
70873 |
0.12 |
chr5_111724741_111725058 | 5.93 |
Gm26897 |
predicted gene, 26897 |
9025 |
0.18 |
chr1_39963056_39963207 | 5.93 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
1024 |
0.61 |
chr5_102328586_102328737 | 5.91 |
Gm42932 |
predicted gene 42932 |
87542 |
0.09 |
chr14_68361701_68361852 | 5.89 |
Gm31227 |
predicted gene, 31227 |
99855 |
0.07 |
chr17_49867296_49868004 | 5.88 |
Kif6 |
kinesin family member 6 |
19978 |
0.17 |
chr14_68124597_68124977 | 5.87 |
Nefm |
neurofilament, medium polypeptide |
59 |
0.97 |
chr14_68083721_68083923 | 5.87 |
Nefl |
neurofilament, light polypeptide |
41 |
0.97 |
chr10_75556393_75556704 | 5.87 |
Lrrc75b |
leucine rich repeat containing 75B |
2654 |
0.16 |
chr4_48924626_48925013 | 5.85 |
Gm12436 |
predicted gene 12436 |
26226 |
0.17 |
chr6_49021180_49021442 | 5.83 |
Gpnmb |
glycoprotein (transmembrane) nmb |
15235 |
0.08 |
chr7_109781147_109782179 | 5.82 |
Nrip3 |
nuclear receptor interacting protein 3 |
118 |
0.94 |
chr2_28296168_28296542 | 5.80 |
Gm13373 |
predicted gene 13373 |
27695 |
0.19 |
chr11_35856666_35857239 | 5.76 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
3398 |
0.24 |
chrX_143932561_143932819 | 5.75 |
Dcx |
doublecortin |
360 |
0.92 |
chr12_117728160_117728414 | 5.75 |
Gm18955 |
predicted gene, 18955 |
4315 |
0.24 |
chr14_79771168_79771431 | 5.73 |
Pcdh8 |
protocadherin 8 |
13 |
0.96 |
chr5_54158151_54158302 | 5.73 |
Stim2 |
stromal interaction molecule 2 |
42369 |
0.18 |
chr7_45361179_45361983 | 5.72 |
Ppfia3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
241 |
0.77 |
chr15_27840550_27840894 | 5.71 |
Trio |
triple functional domain (PTPRF interacting) |
695 |
0.7 |
chr5_84690953_84691175 | 5.69 |
Gm43531 |
predicted gene 43531 |
72358 |
0.13 |
chr5_52688169_52688320 | 5.69 |
Sepsecs |
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase |
18536 |
0.18 |
chr3_16939219_16939438 | 5.68 |
Gm26485 |
predicted gene, 26485 |
116016 |
0.07 |
chr13_83727309_83727854 | 5.67 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr10_87501180_87501623 | 5.66 |
Gm48120 |
predicted gene, 48120 |
6461 |
0.19 |
chr9_72763124_72763344 | 5.66 |
Gm27204 |
predicted gene 27204 |
12991 |
0.11 |
chr14_121564091_121564242 | 5.65 |
Dock9 |
dedicator of cytokinesis 9 |
20560 |
0.17 |
chr15_25360702_25360853 | 5.64 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
28118 |
0.15 |
chr10_17074449_17074835 | 5.61 |
Gm20125 |
predicted gene, 20125 |
11651 |
0.26 |
chr3_34558947_34559118 | 5.60 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1296 |
0.39 |
chr3_134331277_134331428 | 5.60 |
Gm43558 |
predicted gene 43558 |
25940 |
0.15 |
chr2_34771746_34772705 | 5.60 |
Hspa5 |
heat shock protein 5 |
126 |
0.95 |
chrX_96713334_96713515 | 5.59 |
Gpr165 |
G protein-coupled receptor 165 |
17 |
0.99 |
chr10_24595329_24596330 | 5.58 |
Gm15270 |
predicted gene 15270 |
12 |
0.52 |
chr15_73222743_73223248 | 5.54 |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
6755 |
0.18 |
chr12_111672080_111672432 | 5.54 |
Ckb |
creatine kinase, brain |
26 |
0.95 |
chr3_7502758_7503252 | 5.53 |
Zc2hc1a |
zinc finger, C2HC-type containing 1A |
478 |
0.68 |
chr8_79361221_79361765 | 5.53 |
Smad1 |
SMAD family member 1 |
4815 |
0.21 |
chr4_44518914_44519072 | 5.50 |
Mir5120 |
microRNA 5120 |
88575 |
0.07 |
chr9_41612547_41612745 | 5.49 |
Gm48737 |
predicted gene, 48737 |
6346 |
0.12 |
chr13_97410238_97410403 | 5.48 |
Lncenc1 |
long non-coding RNA, embryonic stem cells expressed 1 |
24650 |
0.15 |
chr4_98598734_98598937 | 5.46 |
Gm22625 |
predicted gene, 22625 |
40970 |
0.13 |
chr15_58212852_58213032 | 5.43 |
Gm15943 |
predicted gene 15943 |
1533 |
0.31 |
chr19_26888292_26888443 | 5.41 |
Gm815 |
predicted gene 815 |
2442 |
0.35 |
chr1_39805344_39805500 | 5.41 |
Gm3646 |
predicted gene 3646 |
90 |
0.97 |
chr10_37378360_37378791 | 5.41 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr18_44754207_44754358 | 5.40 |
Mcc |
mutated in colorectal cancers |
29624 |
0.17 |
chr18_44573417_44573637 | 5.40 |
Mcc |
mutated in colorectal cancers |
54011 |
0.14 |
chr10_25918294_25918445 | 5.39 |
Gm47939 |
predicted gene, 47939 |
19090 |
0.17 |
chr6_72958015_72959038 | 5.39 |
Tmsb10 |
thymosin, beta 10 |
38 |
0.97 |
chr4_148000576_148000727 | 5.39 |
Nppa |
natriuretic peptide type A |
71 |
0.94 |
chr9_17289080_17289487 | 5.38 |
Gm2594 |
predicted gene 2594 |
213426 |
0.02 |
chr2_76556286_76556445 | 5.37 |
Osbpl6 |
oxysterol binding protein-like 6 |
8025 |
0.23 |
chr3_108388812_108389040 | 5.37 |
Psrc1 |
proline/serine-rich coiled-coil 1 |
2861 |
0.12 |
chr2_94264645_94265158 | 5.35 |
Mir670hg |
MIR670 host gene (non-protein coding) |
17 |
0.97 |
chr17_78151790_78151946 | 5.34 |
Gm50030 |
predicted gene, 50030 |
6122 |
0.17 |
chr18_25754073_25754459 | 5.33 |
Celf4 |
CUGBP, Elav-like family member 4 |
109 |
0.97 |
chr4_100945474_100945811 | 5.33 |
Cachd1 |
cache domain containing 1 |
48969 |
0.14 |
chr14_123008817_123009020 | 5.32 |
Tmtc4 |
transmembrane and tetratricopeptide repeat containing 4 |
24883 |
0.18 |
chr15_103135415_103135966 | 5.31 |
Gm49477 |
predicted gene, 49477 |
191 |
0.89 |
chr1_104425392_104425677 | 5.30 |
Gm29140 |
predicted gene 29140 |
45882 |
0.17 |
chr2_63452968_63453186 | 5.30 |
Gm23503 |
predicted gene, 23503 |
20883 |
0.24 |
chr18_49117752_49118229 | 5.29 |
Gm18993 |
predicted gene, 18993 |
54566 |
0.18 |
chr1_63995741_63995908 | 5.29 |
Gm13749 |
predicted gene 13749 |
31097 |
0.16 |
chr15_98953471_98953813 | 5.29 |
Tuba1a |
tubulin, alpha 1A |
61 |
0.52 |
chr4_22393242_22393393 | 5.28 |
Gm24607 |
predicted gene, 24607 |
3253 |
0.24 |
chr10_58227289_58228680 | 5.28 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr1_135021264_135021437 | 5.27 |
Lgr6 |
leucine-rich repeat-containing G protein-coupled receptor 6 |
741 |
0.64 |
chr9_99954730_99954881 | 5.27 |
Gm8641 |
predicted gene 8641 |
7416 |
0.2 |
chr14_5000842_5001422 | 5.26 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr10_57783676_57784081 | 5.25 |
Fabp7 |
fatty acid binding protein 7, brain |
1003 |
0.44 |
chr17_3442481_3442659 | 5.25 |
Tiam2 |
T cell lymphoma invasion and metastasis 2 |
2797 |
0.27 |
chrX_58155690_58155914 | 5.25 |
Gm14649 |
predicted gene 14649 |
28684 |
0.21 |
chr1_66387135_66387333 | 5.24 |
Map2 |
microtubule-associated protein 2 |
223 |
0.94 |
chr18_13943807_13943958 | 5.23 |
Zfp521 |
zinc finger protein 521 |
27838 |
0.22 |
chr1_160352341_160352602 | 5.22 |
Rabgap1l |
RAB GTPase activating protein 1-like |
900 |
0.55 |
chr1_53740102_53740664 | 5.20 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
22310 |
0.18 |
chr11_57837001_57837152 | 5.19 |
Hand1 |
heart and neural crest derivatives expressed 1 |
4258 |
0.18 |
chr15_6025556_6025892 | 5.19 |
Gm8047 |
predicted gene 8047 |
9237 |
0.26 |
chr10_59996034_59996185 | 5.18 |
Anapc16 |
anaphase promoting complex subunit 16 |
2201 |
0.28 |
chr18_21084130_21084438 | 5.18 |
Gm6378 |
predicted pseudogene 6378 |
7175 |
0.21 |
chr14_4110111_4111235 | 5.17 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr2_124792603_124792967 | 5.17 |
Gm13994 |
predicted gene 13994 |
84130 |
0.1 |
chr3_138854320_138854669 | 5.16 |
Tspan5 |
tetraspanin 5 |
5999 |
0.23 |
chr1_54925534_54926512 | 5.15 |
Ankrd44 |
ankyrin repeat domain 44 |
331 |
0.88 |
chr18_38212155_38213063 | 5.15 |
Pcdh1 |
protocadherin 1 |
556 |
0.57 |
chr3_63413619_63413824 | 5.15 |
Gm34240 |
predicted gene, 34240 |
25530 |
0.19 |
chr7_79543992_79544179 | 5.14 |
Gm35040 |
predicted gene, 35040 |
8042 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.3 | 9.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.2 | 9.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.8 | 8.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
2.7 | 13.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.4 | 9.5 | GO:0030035 | microspike assembly(GO:0030035) |
2.3 | 4.6 | GO:0060594 | mammary gland specification(GO:0060594) |
2.2 | 6.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.2 | 6.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.1 | 18.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.1 | 12.5 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.1 | 6.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.0 | 8.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.9 | 7.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.9 | 5.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.8 | 7.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.8 | 5.4 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.8 | 5.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.8 | 3.6 | GO:0021564 | vagus nerve development(GO:0021564) |
1.8 | 5.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.7 | 6.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.6 | 4.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.6 | 4.8 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.6 | 4.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.6 | 4.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.6 | 1.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.5 | 3.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.5 | 5.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.4 | 4.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 5.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.4 | 4.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.4 | 4.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.4 | 2.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.4 | 4.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.4 | 4.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 5.2 | GO:0060174 | limb bud formation(GO:0060174) |
1.3 | 3.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.3 | 5.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.3 | 10.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.3 | 2.6 | GO:0060618 | nipple development(GO:0060618) |
1.3 | 3.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.3 | 3.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.2 | 6.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.2 | 2.4 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.2 | 3.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.2 | 10.8 | GO:0050957 | equilibrioception(GO:0050957) |
1.2 | 5.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.1 | 3.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.1 | 3.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.1 | 4.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.1 | 2.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.1 | 6.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.1 | 3.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.1 | 4.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.1 | 5.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.0 | 2.1 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 6.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.0 | 11.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.0 | 7.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.0 | 5.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.0 | 9.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 5.0 | GO:0035989 | tendon development(GO:0035989) |
1.0 | 2.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.0 | 2.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 2.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.0 | 7.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.0 | 2.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 3.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.9 | 2.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 10.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.9 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 2.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 2.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.9 | 1.8 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.9 | 1.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 1.8 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.9 | 7.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.9 | 2.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.9 | 1.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.9 | 3.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.9 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.9 | 2.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.8 | 2.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.8 | 3.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.8 | 2.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.8 | 2.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 2.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 2.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 1.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.8 | 0.8 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.8 | 4.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 3.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 2.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 6.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 0.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 3.1 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 0.8 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.8 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 0.8 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.7 | 1.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 10.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.7 | 8.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 2.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 3.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.7 | 3.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.7 | 2.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 0.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.7 | 2.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 2.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.7 | 5.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 5.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 2.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 8.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.7 | 2.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.7 | 2.1 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.7 | 2.0 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 3.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 2.7 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.7 | 2.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.7 | 2.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.6 | 3.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.6 | 1.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.6 | 4.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.6 | 1.9 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.6 | 1.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 1.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 3.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.8 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.6 | 2.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 2.4 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.6 | 3.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.6 | 2.4 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 1.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.6 | 1.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 2.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 1.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.6 | 1.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.6 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.6 | 1.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 2.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 2.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.6 | 0.6 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.6 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 2.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 0.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.6 | 0.6 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.6 | 1.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 7.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 0.5 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.5 | 4.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.5 | 1.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 1.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 2.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 3.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.5 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 1.1 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 1.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.5 | 3.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.5 | 1.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 4.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.0 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 1.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 6.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 4.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.5 | 2.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.5 | 1.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 1.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 0.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.5 | 1.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 1.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 0.5 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.5 | 2.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 1.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 1.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 1.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 1.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 0.9 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 0.5 | GO:0017085 | response to insecticide(GO:0017085) |
0.5 | 2.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.5 | 1.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 1.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 0.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.5 | 0.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.5 | 1.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 0.5 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.5 | 3.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.5 | 2.3 | GO:0060914 | heart formation(GO:0060914) |
0.5 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 1.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 1.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 1.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 0.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.4 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 3.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 0.9 | GO:0046959 | habituation(GO:0046959) |
0.4 | 3.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.4 | 0.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 0.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 2.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 2.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 5.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 1.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.4 | 7.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 1.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.4 | 0.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.4 | 1.6 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.4 | 2.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.4 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 2.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 0.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 1.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 4.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 0.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.4 | 0.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 1.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.4 | 0.8 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 2.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 3.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.8 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.4 | 3.4 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 1.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 1.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 1.9 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.4 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 18.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 2.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 0.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 1.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 1.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.3 | 1.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 1.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 25.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.7 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 2.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 9.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.3 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 0.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.3 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 2.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 2.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.3 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 2.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.3 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.3 | 1.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.9 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.5 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.9 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 0.9 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 1.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 0.6 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 6.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.6 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.3 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 1.7 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.3 | 0.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.3 | 0.6 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.3 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.3 | 3.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 2.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 1.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.5 | GO:0019230 | proprioception(GO:0019230) |
0.3 | 1.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 3.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.3 | 1.5 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.7 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.5 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 2.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.2 | GO:0048793 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) pronephros development(GO:0048793) |
0.2 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 0.5 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.2 | 0.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 5.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 6.0 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 1.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 1.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.4 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.2 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.8 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.2 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 0.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 1.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 2.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.8 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 2.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.5 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 1.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.9 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 0.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 1.6 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.9 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.3 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.3 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 2.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.2 | GO:0061311 | cell surface receptor signaling pathway involved in heart development(GO:0061311) |
0.2 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.6 | GO:0098868 | bone growth(GO:0098868) |
0.2 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.8 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.2 | 1.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.8 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 4.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.9 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.6 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 8.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.7 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.1 | 1.4 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 2.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 1.0 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 1.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 3.5 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 1.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 1.0 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 1.9 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 0.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 1.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.2 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 1.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 4.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 2.1 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.2 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.1 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.4 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.7 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 1.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 1.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.7 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.2 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.2 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.3 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.2 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.4 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.8 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.0 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.0 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.0 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0014033 | neural crest cell differentiation(GO:0014033) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.9 | 5.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.9 | 14.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 5.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 6.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 5.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.2 | 7.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 11.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 4.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.1 | 4.5 | GO:0033010 | paranodal junction(GO:0033010) |
1.1 | 8.7 | GO:0005883 | neurofilament(GO:0005883) |
0.9 | 3.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.8 | 3.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 20.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 3.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 5.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 11.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 4.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 5.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 3.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.6 | 7.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.5 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 3.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 2.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 11.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 6.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 7.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 8.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 18.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 2.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 1.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 1.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 1.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 3.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 5.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 2.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 2.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 1.5 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 3.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 3.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 4.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 3.5 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 7.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 2.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 15.3 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 10.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 5.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 2.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 10.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 6.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 3.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 2.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 3.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 10.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 14.3 | GO:0031674 | I band(GO:0031674) |
0.2 | 1.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 22.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 2.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 3.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 9.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 7.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 12.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 14.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.8 | 11.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.8 | 8.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.1 | 6.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.1 | 6.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.0 | 6.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.9 | 7.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.8 | 8.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.6 | 4.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.6 | 3.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 8.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.4 | 4.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 5.0 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 3.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.2 | 3.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 7.2 | GO:0030274 | LIM domain binding(GO:0030274) |
1.2 | 4.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 4.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.2 | 3.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.1 | 6.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
1.1 | 3.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.0 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.0 | 3.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 2.9 | GO:0043823 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
1.0 | 3.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 8.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 3.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.9 | 6.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.9 | 5.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 4.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 4.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 4.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.8 | 5.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 6.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.8 | 2.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 4.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 3.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 4.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 3.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 5.9 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 2.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.7 | 2.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 2.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 2.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 5.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 2.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 3.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 6.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.7 | 2.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.7 | 2.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 3.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 3.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 3.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 3.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.6 | 2.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 2.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 1.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 1.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 4.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 5.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.6 | 1.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 2.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 1.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.5 | 2.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.5 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 0.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 6.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 2.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 1.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 6.1 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 3.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 8.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 2.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 8.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 2.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 2.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 1.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 11.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 11.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 1.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 5.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 3.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 9.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 3.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 3.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 6.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 6.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 4.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 4.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 2.1 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 7.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 8.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 7.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 3.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 3.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 1.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 2.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 3.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 2.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 2.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 2.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 5.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 2.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 5.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 3.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 3.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 7.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 4.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 2.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 5.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 2.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 3.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 11.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 5.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 2.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.1 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.2 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 3.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 12.8 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 6.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.8 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 5.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.0 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.0 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 3.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 1.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.7 | 1.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 2.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 12.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 2.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 10.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 4.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 2.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 13.9 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 9.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 2.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 6.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 5.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 6.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 4.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 4.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 7.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 9.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 4.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 4.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 15.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 8.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 21.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 14.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 29.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 0.8 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.8 | 8.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 5.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 8.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 8.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 2.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 6.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 2.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 6.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 10.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 4.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 8.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 0.4 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.4 | 4.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.4 | 7.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 5.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 1.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.4 | 1.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 1.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 3.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 7.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 4.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 4.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 9.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 5.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 4.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 5.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 3.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 9.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 8.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |